In a research report released this morning, Canaccord Genuity analyst Mark Massaro initiated coverage on shares of Illumina, Inc (NASDAQ:ILMN) with a Buy rating …
Illumina, Inc. (NASDAQ:ILMN) announced the launch of Illumina SeqLab, an integrated solution for customers with HiSeq X™ Systems to enable large-scale human whole-genome sequencing …
Illumina, Inc. (NASDAQ:ILMN) announced that a preliminary study retrospectively correlated 10 cases of occult maternal cancer among pregnant women receiving an “aneuploidy detected” or …
Biomed Realty Trust Inc (NYSE:BMR) announced that Illumina, Inc. (NASDAQ:ILMN), a world leader in genomics focused on improving human health by unlocking the …
Annoroad and Illumina, Inc. (NASDAQ:ILMN) announced they have entered into an agreement to jointly develop advanced clinical applications for reproductive health based on next-generation …
Illumina, Inc. (NASDAQ:ILMN) announced the formation of the Global Fertility Alliance, a new collaboration to advance excellence in fertility technologies and processes within …
Illumina, Inc. (NASDAQ:ILMN) announced it has named Pensabio, a life science, analytical instruments and diagnostics distributor, headquartered in Sao Paolo, Brazil, as its …
Illumina, Inc. (NASDAQ:ILMN) announced that the company has filed a new patent infringement suit againstAriosa Diagnostics, Inc.
As previously described here, the Sequenom, Inc. (NASDAQ:SQNM) IP Pool agreement with Illumina, Inc.
Illumina, Inc. (NASDAQ:ILMN) announced its financial results for the first quarter of fiscal year 2015.
